Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (37) Arrow Down
Filter Results: (37) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (120,042)
    • Faculty Publications  (37)

    Show Results For

    • All HBS Web  (120,042)
      • Faculty Publications  (37)

      Tadikonda, Satish K.Remove Tadikonda, Satish K. →

      Page 1 of 37 Results →
      • February 2025
      • Case

      Abiomed: A Change of Heart

      By: Satish Tadikonda, Faith Robertson and William Marks
      After acquiring Impella CardioSystems AG in May 2005, Abiomed Inc., a company focused on cardiac care, ran into a dilemma. Its Impella 2.5 device was approved for use in the European Union, but CEO Michael Minogue had seemingly bet the company's future on the ability... View Details
      Keywords: Mergers and Acquisitions; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Business and Government Relations; Medical Devices and Supplies Industry; European Union; United States
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, Faith Robertson, and William Marks. "Abiomed: A Change of Heart." Harvard Business School Case 825-011, February 2025.
      • February 2025
      • Case

      Abiomed: Clinical Trials and Tribulations

      By: Satish Tadikonda, Faith Robertson and William Marks
      After receiving 510(k) clearance for the Impella 2.5 device, Abiomed had proceeded to conduct a premarket approval (PMA) process as well to prove clinical superiority, earn greater protection, and extend commercial runway. However, in the middle of the clinical trial... View Details
      Keywords: Corporate Disclosure; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Launch; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, Faith Robertson, and William Marks. "Abiomed: Clinical Trials and Tribulations." Harvard Business School Case 825-096, February 2025.
      • November 2024
      • Case

      Eisai's Lecanemab: Where to Next?

      By: Satish Tadikonda and William Marks
      Citation
      Educators
      Related
      Tadikonda, Satish, and William Marks. "Eisai's Lecanemab: Where to Next?" Harvard Business School Case 825-014, November 2024.
      • October 2024
      • Case

      Allurion: Competing in the Age of GLP-1

      By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
      Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
      Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Medical Devices and Supplies Industry; Health Industry; United States; United Kingdom; France; India; Brazil; Middle East
      Citation
      Educators
      Related
      Tadikonda, Satish, Rajiv Lal, David Lane, and Sarah Sasso. "Allurion: Competing in the Age of GLP-1." Harvard Business School Case 525-011, October 2024.
      • August 2024
      • Case

      Sky Therapeutics: Innovating in Digital Therapeutics

      By: Satish Tadikonda, Olivia Reszczynski and William Marks
      Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
      Keywords: Business Startups; Entrepreneurship; Mission and Purpose; Health Care and Treatment; Technological Innovation; Business Strategy; Health Industry; Technology Industry
      Citation
      Educators
      Related
      Tadikonda, Satish, Olivia Reszczynski, and William Marks. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 825-071, August 2024.
      • August 2024
      • Course Overview Note

      Entrepreneurship in the Life Sciences Fall Term 2024: Course Outline and Syllabus

      By: Satish Tadikonda and William Marks
      Citation
      Related
      Tadikonda, Satish, and William Marks. "Entrepreneurship in the Life Sciences Fall Term 2024: Course Outline and Syllabus." Harvard Business School Course Overview Note 825-009, August 2024.
      • August 2024
      • Course Overview Note

      Field Course: Life Sciences Venture Creation Fall Term 2024 - Course Outline and Syllabus

      By: Satish Tadikonda and William Marks
      Citation
      Related
      Tadikonda, Satish, and William Marks. "Field Course: Life Sciences Venture Creation Fall Term 2024 - Course Outline and Syllabus." Harvard Business School Course Overview Note 825-010, August 2024.
      • July 2024
      • Case

      Gates Ventures: Making Alzheimer's a Forgotten Past

      By: Satish Tadikonda, William Marks, Shardule Shah and Calvin Marambo
      After a personal journey and interest in Alzheimer's Disease (AD) by Bill Gates, Gates Ventures set out to find the best way to accelerate innovation in the field of AD. In partnership with the Alzheimer's Drug Discovery Foundation, Gates Ventures created the... View Details
      Keywords: Philanthropy and Charitable Giving; Entrepreneurial Finance; Health Disorders; Mission and Purpose
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, William Marks, Shardule Shah, and Calvin Marambo. "Gates Ventures: Making Alzheimer's a Forgotten Past." Harvard Business School Case 824-075, July 2024.
      • June 2024
      • Case

      Virya Therapeutics: The Certain Uncertainties of Preclinical Development

      By: Satish Tadikonda, William Marks and Shardule Shah
      Citation
      Educators
      Related
      Tadikonda, Satish, William Marks, and Shardule Shah. "Virya Therapeutics: The Certain Uncertainties of Preclinical Development." Harvard Business School Case 824-067, June 2024.
      • June 2024
      • Supplement

      Intarcia: Regulatory Setbacks at a Unicorn (B)

      By: Satish Tadikonda, William Marks and Amanda McEwen
      Citation
      Related
      Tadikonda, Satish, William Marks, and Amanda McEwen. "Intarcia: Regulatory Setbacks at a Unicorn (B)." Harvard Business School Supplement 824-112, June 2024.
      • April 2024
      • Case

      Managing AI Risks in Consumer Banking

      By: Suraj Srinivasan, Satish Tadikonda, Paul Dongha, Manoj Saxena and Radhika Kak
      In early 2024, Ruth Jones, head of digital banking at Signa Bank, a (fictitious) European consumer bank, was thinking about how to best incorporate GenAI capabilities to improve efficiencies and create new ways to improve the customer experience. Where were the biggest... View Details
      Keywords: Customer Relationship Management; AI and Machine Learning; Risk Management; Opportunities; Customization and Personalization; Banking Industry; Europe
      Citation
      Educators
      Purchase
      Related
      Srinivasan, Suraj, Satish Tadikonda, Paul Dongha, Manoj Saxena, and Radhika Kak. "Managing AI Risks in Consumer Banking." Harvard Business School Case 124-093, April 2024.
      • March 2024
      • Supplement

      Miracle Therapeutics (B)

      By: Satish Tadikonda, William Marks and Wendi Yajnik
      Supplements the (A) case. Following on the negotiations detailed in the Miracle Therapeutics (A) case, Beth Sharp and Jennifer Brilliant from Miracle Therapeutics face new challenges with their company's funding and intellectual property (IP) after several missteps.... View Details
      Keywords: Business Startups; Financing and Loans; Intellectual Property; Problems and Challenges; Business or Company Management
      Citation
      Purchase
      Related
      Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024.
      • December 2023 (Revised March 2024)
      • Case

      Manufacturing Moderna's Future

      By: Satish Tadikonda and William Marks
      In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
      Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
      • October 2023 (Revised April 2024)
      • Case

      Veeva Systems: The Next Frontier

      By: Satish Tadikonda and William Marks
      Born out of a desire to bring technological advances in enterprise software into the healthcare vertical, Peter Gassner and Matt Wallach founded Veeva to bring life sciences companies into the digital age for data management in both the commercial and R&D sectors. Over... View Details
      Keywords: Business Model; Governance Compliance; Applications and Software; Growth Management; Expansion; Technology Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, and William Marks. "Veeva Systems: The Next Frontier." Harvard Business School Case 824-074, October 2023. (Revised April 2024.)
      • October 2023 (Revised April 2024)
      • Case

      TetraScience: Unlocking the Power of Scientific Data

      By: Satish Tadikonda and William Marks
      After pivoting from a focus on hardware to a focus on scientific data, TetraScience, led by veteran SaaS executive, Patrick Grady and Founder Spin Wang, has embarked on a journey from nearly cash-out to a player in the scientific data management space. This case... View Details
      Keywords: Business Model; Change Management; Entrepreneurship; Information Management; Business Strategy; Market Entry and Exit; Information Technology Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, and William Marks. "TetraScience: Unlocking the Power of Scientific Data." Harvard Business School Case 824-072, October 2023. (Revised April 2024.)
      • October 2023 (Revised May 2024)
      • Case

      Thermo Fisher Scientific: Foray into Contract Research

      By: Satish Tadikonda, William Marks and Kevin Emancipator
      After publicly declaring that they would not enter the contract research organization (CRO) business in 2017, Thermo Fisher purchased Pharmaceutical Product Development (PPD), one of the biggest players in the CRO space, in 2021. Much had changed in the intervening... View Details
      Keywords: Mergers and Acquisitions; Customer Focus and Relationships; Corporate Strategy; Organizational Change and Adaptation; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, William Marks, and Kevin Emancipator. "Thermo Fisher Scientific: Foray into Contract Research." Harvard Business School Case 824-073, October 2023. (Revised May 2024.)
      • October 2023 (Revised July 2024)
      • Case

      Alnylam: A Loud Silence (A)

      By: Satish Tadikonda, William Marks and Shardule Shah
      Citation
      Educators
      Related
      Tadikonda, Satish, William Marks, and Shardule Shah. "Alnylam: A Loud Silence (A)." Harvard Business School Case 824-041, October 2023. (Revised July 2024.)
      • October 2023 (Revised August 2024)
      • Supplement

      Alnylam: A Loud Silence (B)

      By: Satish Tadikonda, William Marks and Shardule Shah
      Citation
      Related
      Tadikonda, Satish, William Marks, and Shardule Shah. "Alnylam: A Loud Silence (B)." Harvard Business School Supplement 824-042, October 2023. (Revised August 2024.)
      • October 2023 (Revised June 2024)
      • Case

      Catalent: Catalyzing the Next Era of Growth

      By: Satish Tadikonda, William Marks and Kevin Emancipator
      Catalent's newly appointed CEO, Alessandro Maselli, experienced the highs of the pharmaceutical contract development manufacturing (CDMO) space during COVID-19 while helping Moderna and others bring vaccines to market quickly and safely. After rushing to add capacity... View Details
      Keywords: Leadership; Business or Company Management; Organizational Change and Adaptation; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, William Marks, and Kevin Emancipator. "Catalent: Catalyzing the Next Era of Growth." Harvard Business School Case 824-016, October 2023. (Revised June 2024.)
      • October 2023 (Revised June 2024)
      • Case

      Revvity: A Symbol of Change

      By: Satish Tadikonda and William Marks
      After selling the PerkinElmer name and several ancillary business units, Prahlad Singh (CEO) and his team at the newly christened Revvity faced a challenge on how best to capitalize on the opportunities ahead for the business and emerge as winners within the Life... View Details
      Keywords: Business Model; Organizational Change and Adaptation; Corporate Strategy
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, and William Marks. "Revvity: A Symbol of Change." Harvard Business School Case 824-071, October 2023. (Revised June 2024.)
      • 1
      • 2
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.